Unsupervised capture and profiling of rare immune cells using multi-directional magnetic ratcheting.

Immunotherapies (IT) require induction, expansion, and maintenance of specific changes to a patient's immune cell repertoire which yield a therapeutic benefit. Recently, mechanistic understanding of these changes at the cellular level has revealed that IT results in complex phenotypic transitions in target cells, and that therapeutic effectiveness may be predicted by monitoring these transitions during therapy. However, monitoring will require unique tools that enable capture, manipulation, and profiling of rare immune cell populations. In this study, we introduce a method of automated and unsupervised separation and processing of rare immune cells, using high-force and multidimensional magnetic ratcheting (MR). We demonstrate capture of target immune cells using samples with up to 1 : 10 000 target cell to background cell ratios from input volumes as small as 25 microliters (i.e. a low volume and low cell frequency sample sparing assay interface). Cell capture is shown to achieve up to 90% capture efficiency and purity, and captured cell analysis is shown using both on-chip culture/activity assays and off-chip ejection and nucleic acid analysis. These results demonstrate that multi-directional magnetic ratcheting offers a unique separation system for dealing with blood cell samples that contain either rare cells or significantly small volumes, and the "sample sparing" capability leads to an expanded spectrum of parameters that can be measured. These tools will be paramount to advancing techniques for immune monitoring under conditions in which both the sample volume and number of antigen-specific target cells are often exceedingly small, including during IT and treatment of allergy, asthma, autoimmunity, immunodeficiency, cell based therapy, transplantation, and infection.

[1]  I. Hellmann,et al.  Comparative Analysis of Single-Cell RNA Sequencing Methods , 2016, bioRxiv.

[2]  Christoph A Merten,et al.  Microfluidic single-cell technology in immunology and antibody screening. , 2017, Molecular aspects of medicine.

[3]  William W Kwok,et al.  CD4+ T cells recognize unique and conserved 2009 H1N1 influenza hemagglutinin epitopes after natural infection and vaccination. , 2013, International immunology.

[4]  Evan Z. Macosko,et al.  Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets , 2015, Cell.

[5]  Dino Di Carlo,et al.  Quantitative Magnetic Separation of Particles and Cells Using Gradient Magnetic Ratcheting. , 2016, Small.

[6]  C. Baecher-Allan,et al.  Identification of T helper type 1–like, Foxp3+ regulatory T cells in human autoimmune disease , 2011, Nature Medicine.

[7]  E. James,et al.  Yellow Fever Vaccination Elicits Broad Functional CD4+ T Cell Responses That Recognize Structural and Nonstructural Proteins , 2013, Journal of Virology.

[8]  J. C. Love,et al.  Seq-Well: portable, low-cost RNA sequencing of single cells at high throughput , 2017, Nature Methods.

[9]  James A. Eddy,et al.  Single-Cell RNA Sequencing Reveals Expanded Clones of Islet Antigen-Reactive CD4+ T Cells in Peripheral Blood of Subjects with Type 1 Diabetes , 2017, The Journal of Immunology.

[10]  A. B. Lyons,et al.  Determination of lymphocyte division by flow cytometry. , 1994, Journal of immunological methods.

[11]  David L. Porter,et al.  Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia , 2015, Science Translational Medicine.

[12]  W. Zou,et al.  Mechanistic insights into cancer immunity and immunotherapy , 2018, Cellular & Molecular Immunology.

[13]  L. Terstappen,et al.  Sample Preparation Methods Following CellSearch Approach Compatible of Single-Cell Whole-Genome Amplification: An Overview. , 2015, Methods in molecular biology.

[14]  Xinjie Zhang,et al.  Microfluidic Passive Valve with Ultra-Low Threshold Pressure for High-Throughput Liquid Delivery , 2019, Micromachines.

[15]  A. Kermode,et al.  Circulating immune cells in multiple sclerosis , 2017, Clinical and experimental immunology.

[16]  P. Demoly,et al.  Perspectives in allergen immunotherapy: 2017 and beyond , 2018, Allergy.

[17]  Alexander Dobin,et al.  Mapping RNA‐seq Reads with STAR , 2015, Current protocols in bioinformatics.

[18]  J. C. Love,et al.  Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis , 2015, Science Translational Medicine.

[19]  A. Scheffold,et al.  Antigen-Reactive T Cell Enrichment for Direct, High-Resolution Analysis of the Human Naive and Memory Th Cell Repertoire , 2013, The Journal of Immunology.

[20]  E. James,et al.  Assessment of Seasonal Influenza A Virus-Specific CD4 T-Cell Responses to 2009 Pandemic H1N1 Swine-Origin Influenza A Virus , 2010, Journal of Virology.

[21]  R. Satija,et al.  Single-cell RNA sequencing to explore immune cell heterogeneity , 2017, Nature Reviews Immunology.

[22]  Stephen J. Galli,et al.  Successful immunotherapy induces previously unidentified allergen-specific CD4+ T-cell subsets , 2016, Proceedings of the National Academy of Sciences.

[23]  P. Linsley,et al.  A phenotypically and functionally distinct human TH2 cell subpopulation is associated with allergic disorders , 2017, Science Translational Medicine.

[24]  D. Hafler,et al.  Increased Frequencies of Myelin Oligodendrocyte Glycoprotein/MHC Class II-Binding CD4 Cells in Patients with Multiple Sclerosis , 2011, The Journal of Immunology.

[25]  A. Togias,et al.  Synchronous immune alterations mirror clinical response during allergen immunotherapy , 2017, The Journal of allergy and clinical immunology.